Roche said today it has agreed to acquire Viewics, a software company focused on laboratory business analytics, for an undisclosed price.
Roche said the acquisition would expand its Integrated Core Lab business, focused on business consultation relating to the establishment of a scientific and medical laboratory, by adding business analytics capabilities designed to help labs make faster, data-informed decisions on their operations and processes.
“The Viewics solution offers our customers insights at their fingertips, uncovering potential value and profitability drivers in lab operations, and indicators to improve overall quality of care,” Roland Diggelmann, CEO Roche Diagnostics, said in a statement. “We are excited that Viewics, Inc. will be joining the Roche Group, as it will help us to support our customers around the world in improving their lab performance and processes.”
Roche Diagnostics generated CHF 11.473 billion ($11.607 billion) in sales last year, up 7% at constant exchange rates over 2015—accounting for nearly 23% of the CHF 50.576 ($51.168 billion) generated by the entire Roche Group. During the first half of 2017, Roche Diagnostics racked up CHF 5.823 billion ($5.892 billion) in sales, up 5% year-over-year at constant exchange rates.
Viewics’ namesake solution is a cloud-based offering focused on extracting, cleansing, transforming and augmenting data, with the goal of allowing labs to efficiently integrate big data from a variety of IT systems in and outside the lab.
The HIPAA-compliant solution is designed to resolve problems that laboratory IT staff may encounter when using generic business intelligence solutions, traditional data warehousing, or extraction methodologies. Viewics says its solution is secure, infrastructure-agnostic, interactive, and accessible from multiple devices such as smart phones, tablets, and desktop computers.
“The Viewics platform generates insights that can inform real-time decisions about costs, laboratory performance, and many other areas affecting today’s modern healthcare organizations,” Viewics CEO Keith Laughman added. “We are looking forward to working with our Roche colleagues in helping to support the lab’s critical role in healthcare delivery.”
Roche said it will acquire all shares of Viewics, in a deal that is expected to close on Tuesday, Roche said.
Founded in 2010 in Sunnyvale, CA, Viewics is now headquartered in San Jose, CA, and has employees in the U.S. and in Pune, India, where a subsidiary is based.
“We founded Viewics with the belief that unlocking the value of data would drive immense value for our customers. With Roche’s expertise and strong alignment within our teams, we are excited to embark on this next phase of Viewics’ journey and jointly deliver on this mission,” Viewics Founder and President Dhiren Bhatia stated.
